1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        MEA Immunohistochemistry Market – By Product

1.3.2        MEA Immunohistochemistry Market – By Application

1.3.3        MEA Immunohistochemistry Market – By End User

1.3.4        MEA Immunohistochemistry Market – By Country

2.             Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             MEA Immunohistochemistry Market – Market Landscape

4.1       Overview

4.2       MEA PEST Analysis

4.3       Experts Opinion

5.             MEA Immunohistochemistry Market – Key Market Dynamics

5.1       Market Drivers

5.1.1        Surging Incidences of Chronic and Infectious Diseases

5.1.2        Escalating R&D Investments by Biotechnology & Biopharmaceutical Companies

5.2       Key Market Restraints

5.2.1        Issues Related to Immunohistochemistry

5.3       Key Market Opportunities

5.3.1        Growing Opportunities in Emerging Countries

5.4       Future Trends

5.4.1        Rising Acceptance of Automation in Immunohistochemistry

5.5       Impact Analysis

6.             Immunohistochemistry Market – MEA Analysis

6.1       MEA Immunohistochemistry Market Revenue Forecast and Analysis

7.             MEA Immunohistochemistry Market Analysis– By Product

7.1       Overview

7.2       MEA Immunohistochemistry Market, By Product 2021 & 2028 (%)

7.3       Antibodies

7.3.1        Overview

7.3.2        Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.3        Primary Antibodies

7.3.3.1      Overview

7.3.3.2      Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.4        Secondary Antibodies

7.3.4.1      Overview

7.3.4.2      Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4       Equipment Market

7.4.1        Overview

7.4.2        Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.3        Slide Staining Systems

7.4.3.1      Overview

7.4.3.2      Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.4        Tissue Microarrays

7.4.4.1      Overview

7.4.4.2      Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.5        Tissue Processing Systems

7.4.5.1      Overview

7.4.5.2      Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.6        Slide Scanners

7.4.6.1      Overview

7.4.6.2      Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.7        Other Equipments

7.4.7.1      Overview

7.4.7.2      Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5       Reagents Market

7.5.1        Overview

7.5.2        Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.3        Histological Stains

7.5.3.1      Overview

7.5.3.2      Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.4        Blocking Sera & Reagents Market

7.5.4.1      Overview

7.5.4.2      Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.5        Chromogenic Substrates Market

7.5.5.1      Overview

7.5.5.2      Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.6        Stabilizers

7.5.6.1      Overview

7.5.6.2      Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.7        Proteolytic Enzymes

7.5.7.1      Overview

7.5.7.2      Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.8        Organic Solvents

7.5.8.1      Overview

7.5.8.2      Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.9        Fixation Reagents

7.5.9.1      Overview

7.5.9.2      Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.10     Diluents

7.5.10.1    Overview

7.5.10.2    Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.6       Kits Market

7.6.1        Overview

7.6.2        Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

8.             MEA Immunohistochemistry Market Analysis – By Application

8.1       Overview

8.2       MEA Immunohistochemistry Market Share by Application 2021 & 2028 (%)

8.3       Diagnostics

8.3.1        Overview

8.3.2        Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

8.3.3        Cancer

8.3.3.1      Overview

8.3.3.2      Cancer Market Revenue and Forecast to 2028 (US$ Mn)

8.3.4        Infectious Diseases

8.3.4.1      Overview

8.3.4.2      Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.5        Autoimmune Diseases

8.3.5.1      Overview

8.3.5.2      Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.6        Diabetes Mellitus

8.3.6.1      Overview

8.3.6.2      Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)

8.3.7        Nephrological Diseases

8.3.7.1      Overview

8.3.7.2      Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.8        Others

8.3.8.1      Overview

8.3.8.2      Others Market Revenue and Forecast to 2028 (US$ Mn)

8.4       Drug Testing

8.4.1        Overview

8.4.2        Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)

9.             MEA Immunohistochemistry Market Analysis– By End User

9.1       Overview

9.2       MEA Immunohistochemistry Market, By End User 2021 & 2028 (%)

9.3       Hospital & Diagnostic Laboratories

9.3.1        Overview

9.3.2        Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.4       Research Institutes

9.4.1        Overview

9.4.2        Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.5       Others

9.5.1        Overview

9.5.2        Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.          MEA Immunohistochemistry Market – Country Analysis

10.1    MEA Immunohistochemistry Market Revenue and Forecasts To 2028

10.1.1     MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1    UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.1    UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.2    UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.1.2.1        UAE Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.1.2.2        UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.1.2.3        UAE Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.1.3    UAE Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.1.3.1        UAE Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.1.4    UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.1.2    Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.1    Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.2    Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.2.2.1        Saudi Arabia Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.2.2.2        Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.2.2.3        Saudi Arabia Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.2.3    Saudi Arabia Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.2.3.1        Saudi Arabia Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.2.4    Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.1.3    South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.1    South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.2    South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.3.2.1        South Africa Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.3.2.2        South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.3.2.3        South Africa Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.3.3    South Africa Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.3.3.1        South Africa Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.3.4    South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.1.4    Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.1    Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.2    Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.4.2.1        Rest of MEA Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.4.2.2        Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.4.2.3        Rest of MEA Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.4.3    Rest of MEA Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.4.3.1        Rest of MEA Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.4.4    Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

11.          Impact Of COVID-19 Pandemic on MEA Immunohistochemistry Market

11.1    MEA: Impact Assessment of COVID-19 Pandemic

12.          Industry Landscape

12.1    Overview

12.2    Organic Developments

12.2.1     Overview

12.3    Inorganic developments

12.3.1     Overview

13.          Company Profiles

13.1    F. HOFFMANN-LA ROCHE LTD.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    MERCK KGaA

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    PerkinElmer Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    THERMO FISHER SCIENTIFIC INC.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    Abcam plc

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    Agilent Technologies, Inc.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    BIO-RAD LABORATORIES INC.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    Danaher

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    Bio SB

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

14.          Appendix

14.1    About The Insight Partners

14.2    Glossary of Terms

Table 1.             MEA Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Table 2.             UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 3.             UAE Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 4.             UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 5.             UAE Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 6.             UAE Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 7.             UAE Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 8.             UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 9.             Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 10.          Saudi Arabia Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 11.          Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 12.          Saudi Arabia Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 13.          Saudi Arabia Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 14.          Saudi Arabia Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 15.          Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 16.          South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 17.          South Africa Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 18.          South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 19.          South Africa Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 20.          South Africa Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 21.          South Africa Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 22.          South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 23.          Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 24.          Rest of MEA Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 25.          Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 26.          Rest of MEA Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 27.          Rest of MEA Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 28.          Rest of MEA Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 29.          Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 30.          Organic Developments Done By Companies

Table 31.          Inorganic developments done by Companies

Table 32.          Glossary of Terms

Figure 1.           MEA Immunohistochemistry Market Segmentation

Figure 2.           MEA Immunohistochemistry Market Segmentation, By Country

Figure 3.           MEA Immunohistochemistry Market Overview

Figure 4.           Antibodies Segment Held the Largest Share of the Market in 2021

Figure 5.           The UAE to Show Significant Growth During Forecast Period

Figure 6.           MEA PEST Analysis

Figure 7.           Impact Analysis of Drivers and Restraints Pertaining to MEA Immunohistochemistry Market

Figure 8.           MEA Immunohistochemistry Market – Revenue Forecast and Analysis

Figure 9.           MEA Immunohistochemistry Market, by Product 2021 & 2028 (%)

Figure 10.        MEA Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        MEA Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        MEA Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        MEA Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        MEA Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        MEA Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16.        MEA Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        MEA Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18.        MEA Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19.        MEA Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20.        MEA Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21.        MEA Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22.        MEA Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23.        MEA Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24.        MEA Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25.        MEA Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26.        MEA Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27.        MEA Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28.        MEA Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29.        MEA Immunohistochemistry Market Share by Application 2021 & 2028 (%)

Figure 30.        MEA Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 31.        MEA Cancer Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 32.        MEA Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 33.        MEA Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 34.        MEA Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 35.        MEA Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 36.        MEA Others Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 37.        MEA Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 38.        MEA Immunohistochemistry Market, by End User 2021 & 2028 (%)

Figure 39.        MEA Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40.        MEA Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41.        MEA Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42.        MEA Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ Mn)

Figure 43.        MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

Figure 44.        UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 45.        Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 46.        South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 47.        Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 48.        Impact of COVID-19 Pandemic in MEA Country Markets